Clinical trial

Bio-equivalence Study Between SAPHRIS and Asenapine

NCT01948024

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE1

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2021-04-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Bipolar Disorderunresolved

Interventions

SAPHRISDRUG

AsenapineDRUG

Sponsors & collaborators

Sun Pharmaceutical Industries Limitedlead sponsor

bioRASI, LLCcollaborator

Mapped research locations

AtlantaGeorgia, United States1 MiamiFlorida, United States1 CharlotteNorth Carolina, United States1 Little RockArkansas, United States1 Garden GroveCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01948024 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.